Company Profile

SHREE GANESH REMEDIES LTD.

NSE : NABSE : 540737ISIN CODE : INE414Y01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE299.801.65 (+0.55 % )
PREV CLOSE (Rs.) 298.15
OPEN PRICE (Rs.) 307.10
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 7599
TODAY'S LOW / HIGH (Rs.)293.20 307.10
52 WK LOW / HIGH (Rs.) 60.07 349
NSE
This Company is not listed in NSE

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.50
TTM EPS (Rs.) 9.75
P/E Ratio 30.68
Book Value (Rs.) 43.10
Face Value (Rs.) 10
MCap (Rs. in Mn) 2991.93
Price/Earning (TTM) 23.98
Price/Sales (TTM) 6.10
Price/Book (MRQ) 6.94
PAT Margin (%) 16.47
ROCE (%) 32.63
Incorporation Year : 1995

Management Info :

- Chairman Chandulal Manubhai Kothia - Managing Director

Registered Office :

Address : Plot No. 6011,G I D C, ,
Ankleshwar,
Gujarat-393002

Phone : 02641 22777

Registrar's Details : Bigshare Services Pvt Ltd
Bharat Tin Works Building,1st floor, Opp. Vasant Oasis,Andheri (E),Mumbai
Listing : BSE
NEWS More
03May05-03-2021$Shree Ganesh Remedies board recommends final dividend Shree Ganesh Remedies board

Shree Ganesh Remedies has informed that the Board of Directors of the Company at its meeting held on May 03, 2021, has recommended Final Dividend of Rs 1.75 per Equity Share of Face Value of Rs 10 each for the Financial Year ended March 31, 2021, subject to approval of the Shareholders at the ensuing Annual General Meeting of the Company.

The above information is a part of company’s filings submitted to BSE.

Shree Ganesh Remedies has informed that the Board of Directors..
03May05-03-2021$Shree Ganesh Remedies informs about outcome of board meeting Shree Ganesh Remedies inform

Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) read with Schedule III to the said Regulations, Shree Ganesh Remedies has informed that the Board of Directors of the Company, at its Meeting held today, i.e., on Monday, May 03, 2021 (which commenced at 1l.00 a.m. and concluded at 11:45 am.), have approved/ noted the following: Audited Financial Results for the quarter and Financial year ended March 31, 2021, and recommendation of Final Dividend for the Financial Year 2020-21.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 33 of the Securities and Exchange Board..
03May05-03-2021$ Board recommends Final Dividend Board recommends Final Divi
Shree Ganesh Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 03, 2021, inter alia, has recommended Final Dividend of Rs. 1.75/ - (Rupee One and Paisa Seventy Five Only) per Equity Share of Face Value of Rs. 10/- (Rupees Ten Only) each for the Financial Year ended March 31, 2021, subject to approval of the Shareholders at the ensuing Annual General Meeting of the Company.
Shree Ganesh Remedies Ltd has informed BSE that the Board of Di..
19Apr04-19-2021$ Board Meeting Intimation for Notice Of Board Meeting Board Meeting Intimation fo
Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/05/2021 ,inter alia, to consider and approve In compliance of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that a meeting of the Board of Directors of the Company will be held on Monday, May 03, 2021 at the registered office of the Company to consider amongst other business, inter-alia, the following: 1. Approval of Audited Financial Results of the Company for the quarter and financial year ended on March 31, 2021. 2. Recommendation of Final Dividend on the Equity Shares, if any.
Shree Ganesh Remedies Ltdhas informed BSE that the meeting of t..
19Apr04-19-2021$ Board to consider Final Dividend Board to consider Final Div
Shree Ganesh Remedies Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 03, 2021, to consider amongst other business, inter-alia, the following: 1. Approval of Audited Financial Results of the Company for the qu arter and financial year ended on March 31, 2021. 2. Recommendation of Final Dividend on the Equity Shares, if any. In accordance to the Code of Conduct of the Company for prohibition of insider trading, th e "Trading Window" for dealing / trading in the shares of the Company was closed from April 01, 2021 and shall remain closed till 48 hours from the closure of the Board Meeting.
Shree Ganesh Remedies Ltd has informed BSE that a meeting of th..
Financials More
Rs. in Millions
QTR Mar 21 ANNUAL 21
Net Profit30.2997.5299999999999
Gross Profit 40.41 129.49
Operating Profit 52.39157.42
Net Sales 153.7490.82
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
NGL Fine-Chem (BSE)
 1679.60 (4.62%)
M.Cap ( in Cr)
1037.66
Ajanta Pharma (BSE)
 2002.95 (3.11%)
M.Cap ( in Cr)
17398.94
Solara Active Pharma (BSE)
 1742.70 (2.80%)
M.Cap ( in Cr)
6280.52
Themis Medicare (BSE)
 465.55 (5.54%)
M.Cap ( in Cr)
440.91
Cadila Healthcare (BSE)
 646.95 (2.74%)
M.Cap ( in Cr)
66231.03
Shareholding Pattern More
PROMOTERS 68.39 %
NON-INSTITUTION 31.61 %
MUTUAL FUNDS/UTI 0 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS
Scheme NameHold(%)
No Data Found
F & O Quotes